|
Volumn 56, Issue 4, 2000, Pages 255-260
|
Phase II trial evaluating the effect of megestrol acetate-prednisolone combination for the treatment of anorexia in the palliative-care phase of lung cancer;Essai de phase II evaluant l'effet d'une association acetate de megestrol et prednisolone dans le traitement de l'anorexie au cours du cancer bronchique en phase palliative
|
Author keywords
Anorexia; Corticosteroids; Lung cancer; Palliative care; Progesterone derivatives; Weight loss
|
Indexed keywords
MEGESTROL ACETATE;
PREDNISOLONE;
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BODY WEIGHT;
CALORIC INTAKE;
CANCER PALLIATIVE THERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
LUNG CANCER;
PHASE 2 CLINICAL TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
COMPARATIVE STUDY;
DRUG COMBINATION;
LUNG TUMOR;
MALE;
MIDDLE AGED;
PALLIATIVE THERAPY;
STATISTICAL ANALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANOREXIA;
ANTI-INFLAMMATORY AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
DATA INTERPRETATION, STATISTICAL;
DRUG THERAPY, COMBINATION;
HUMANS;
LUNG NEOPLASMS;
MALE;
MEGESTROL ACETATE;
MIDDLE AGED;
PALLIATIVE CARE;
PREDNISOLONE;
|
EID: 0034267459
PISSN: 00325821
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (22)
|